Quest Diagnostics (NY:DGX)

251.82 -1.10 (-0.43%)

Official Closing Price Updated: 4:10 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL ↗

March 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Quest Diagnostics Incorporated (NYSE:DGX) Investor Notice: Investigation over Possible Securities Laws Violations ↗

March 23, 2022

San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Quest Diagnostics Incorporated was under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

7 Healthcare Stocks to Buy for the Long Term ↗

March 21, 2022

When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks.

Via InvestorPlace

This Foreboding Sign Looms Over Quest Diagnostics's Chart ↗

March 03, 2022

If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this...

Via Benzinga

Earnings Scheduled For February 3, 2022 ↗

February 03, 2022

Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

February 28, 2022

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...

Via Benzinga

Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market

February 16, 2022

Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years....

Via FinancialNewsMedia

What 8 Analyst Ratings Have To Say About Quest Diagnostics ↗

February 14, 2022

Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total...

Via Benzinga

Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services ↗

February 03, 2022

Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected

Via Benzinga

FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year

February 03, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation ↗

February 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Quest Diagnostics Q4 Earnings ↗

February 03, 2022

Quest Diagnostics (NYSE:DGX) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Via Benzinga

Walmart and Quest Diagnostics Empower People to Take Control of Their Healthcare Through New Consumer-Initiated Laboratory Testing Solution Powered by QuestDirect™ Through Walmart.com

February 02, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022 ↗

February 02, 2022

Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09...

Via Benzinga

Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Sixth Consecutive Year

January 31, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

Project HOPE Awarded Grant to Reduce Transmission of COVID-19 Variants in Long-term Care Facilities

January 26, 2022

SOURCE: Quest Diagnostics

Via 3BL Media

7 Undervalued Stocks That Won’t Stay That Way for Long ↗

January 25, 2022

With growing concerns about stability inducing significant fear, contrarians may have an opportunity with undervalued stocks.

Via InvestorPlace

FeganScott Announces Investigation into Prenatal Testing Options Revealing Flawed Genetic Results

January 17, 2022

--News Direct--

Via News Direct

26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble ↗

January 14, 2022

There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks.

Via Talk Markets

Monday Is Your Last Chance To Buy Quest Diagnostics Before The Dividend Payout ↗

January 13, 2022

Monday marks the last chance for investors to receive the next dividend payout from Quest Diagnostics. What's Happening (NYSE:

Via Benzinga

Quest Diagnostics Inc Slammed After Earnings, Here’s Where It's Going ↗

January 12, 2022

The next major support level for Quest Diagnostics Inc stock will be around the $140.00 level. This support area is where the stock broke out to the upside in early November 2021.

Via Talk Markets

Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus ↗

January 12, 2022

Quest Diagnostics Inc (NYSE: DGX) expects Q4 sales of $2.74 billion, a decrease of 9% Y/Y, beating the consensus of $2.54 billion. The company noted preliminary Q4...

Via Benzinga

Free COVID Tests: What Stocks Will Benefit? ↗

December 23, 2021

The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.

Via Talk Markets

QDEL Stock Alert: What Is Going on With Quidel Today? ↗

December 20, 2021

The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result.

Via InvestorPlace

Quest Diagnostics Earns Gold Status in American Heart Association's 2021 Workplace Health Achievement Index

December 16, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Price Over Earnings Overview: Quest Diagnostics ↗

December 14, 2021

In the current session, Quest Diagnostics Inc. (NYSE:DGX) is trading at $163.60, after a 0.21% gain. Over the past month, the stock increased by 10.55%, and in the past...

Via Benzinga

Quest Announces Annual Sustainability Awards

December 08, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Topics Emissions

Quest Provides Needed Support for Global Anti-Hate Summit

December 03, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Rising Cases of Early-Onset Colorectal Cancer Calls for Expanded Biotech Screening Methods

December 01, 2021

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – December 1, 2021 – Early onset colorectal cancer is currently on the rise [[1]], according to a new study [[2]] from the...

Via FinancialNewsMedia

Choose Healthy Life: National Black Clergy: Turning the Tide

November 30, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.